Quintiles to Provide Specialized MSUs for Delcath (DCTH) CHEMOSAT Launch
Tweet
Share
E-mailGet Alerts DCTH Hot Sheet
Join SI Premium – FREE
Delcath Systems, Inc. (Nasdaq: DCTH) reports that Quintiles will provide a specialized team of Medical Science Liaisons (MSLs) to support the launch of the Hepatic CHEMOSAT Delivery system for the treatment of cancers in the liver in France, Germany, Italy, Netherlands, Spain, Ireland and the United Kingdom. In addition, it will provide medical communication to support patient advocacy, key opinion leader development, and field force materials.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gap Inc. names Michael Francis as Old Navy CEO effective November
- Nvidia to present at Goldman Sachs tech conference in September
- McEwen Copper closes $240M loan to fund Los Azules copper project
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
